Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy.

A major challenge to HIV eradication strategies is the lack of an accurate measurement of the total burden of replication-competent HIV (the "reservoir"). We assessed the association of anti-HIV antibody responses and the estimated size of the reservoir during antiretroviral therapy (ART)....

Full description

Bibliographic Details
Main Authors: Sulggi A Lee, Peter Bacchetti, Nicolas Chomont, Remi Fromentin, Sharon R Lewin, Una O'Doherty, Sarah Palmer, Douglas D Richman, Janet D Siliciano, Steven A Yukl, Steven G Deeks, Peter D Burbelo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4970722?pdf=render
_version_ 1818026062257324032
author Sulggi A Lee
Peter Bacchetti
Nicolas Chomont
Remi Fromentin
Sharon R Lewin
Una O'Doherty
Sarah Palmer
Douglas D Richman
Janet D Siliciano
Steven A Yukl
Steven G Deeks
Peter D Burbelo
author_facet Sulggi A Lee
Peter Bacchetti
Nicolas Chomont
Remi Fromentin
Sharon R Lewin
Una O'Doherty
Sarah Palmer
Douglas D Richman
Janet D Siliciano
Steven A Yukl
Steven G Deeks
Peter D Burbelo
author_sort Sulggi A Lee
collection DOAJ
description A major challenge to HIV eradication strategies is the lack of an accurate measurement of the total burden of replication-competent HIV (the "reservoir"). We assessed the association of anti-HIV antibody responses and the estimated size of the reservoir during antiretroviral therapy (ART).We evaluated anti-HIV antibody profiles using luciferase immunoprecipitation systems (LIPS) assay in relation to several blood-based HIV reservoir measures: total and 2-LTR DNA (rtPCR or droplet digital PCR); integrated DNA (Alu PCR); unspliced RNA (rtPCR), multiply-spliced RNA (TILDA), residual plasma HIV RNA (single copy PCR), and replication-competent virus (outgrowth assay). We also assessed total HIV DNA and RNA in gut-associated lymphoid tissue (rtPCR). Spearman correlations and linear regressions were performed using log-transformed blood- or tissue-based reservoir measurements as predictors and log-transformed antibody levels as outcome variables.Among 51 chronically HIV-infected ART-suppressed participants (median age = 57, nadir CD4+ count = 196 cells/mm3, ART duration = 9 years), the most statistically significant associations were between antibody responses to integrase and HIV RNA in gut-associated lymphoid tissue (1.17 fold-increase per two-fold RNA increase, P = 0.004) and between antibody responses to matrix and integrated HIV DNA in resting CD4+ T cells (0.35 fold-decrease per two-fold DNA increase, P = 0.003). However, these associations were not statistically significant after a stringent Bonferroni-adjustment of P<0.00045. Multivariate models including age and duration of ART did not markedly alter results.Our findings suggest that anti-HIV antibody responses may reflect the size of the HIV reservoir during chronic treated HIV disease, possibly via antigen recognition in reservoir sites. Larger, prospective studies are needed to validate the utility of antibody levels as a measure of the total body burden of HIV during treatment.
first_indexed 2024-12-10T04:26:02Z
format Article
id doaj.art-498b9450506b48bcbf6e3b27f7a7cb95
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T04:26:02Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-498b9450506b48bcbf6e3b27f7a7cb952022-12-22T02:02:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01118e016019210.1371/journal.pone.0160192Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy.Sulggi A LeePeter BacchettiNicolas ChomontRemi FromentinSharon R LewinUna O'DohertySarah PalmerDouglas D RichmanJanet D SilicianoSteven A YuklSteven G DeeksPeter D BurbeloA major challenge to HIV eradication strategies is the lack of an accurate measurement of the total burden of replication-competent HIV (the "reservoir"). We assessed the association of anti-HIV antibody responses and the estimated size of the reservoir during antiretroviral therapy (ART).We evaluated anti-HIV antibody profiles using luciferase immunoprecipitation systems (LIPS) assay in relation to several blood-based HIV reservoir measures: total and 2-LTR DNA (rtPCR or droplet digital PCR); integrated DNA (Alu PCR); unspliced RNA (rtPCR), multiply-spliced RNA (TILDA), residual plasma HIV RNA (single copy PCR), and replication-competent virus (outgrowth assay). We also assessed total HIV DNA and RNA in gut-associated lymphoid tissue (rtPCR). Spearman correlations and linear regressions were performed using log-transformed blood- or tissue-based reservoir measurements as predictors and log-transformed antibody levels as outcome variables.Among 51 chronically HIV-infected ART-suppressed participants (median age = 57, nadir CD4+ count = 196 cells/mm3, ART duration = 9 years), the most statistically significant associations were between antibody responses to integrase and HIV RNA in gut-associated lymphoid tissue (1.17 fold-increase per two-fold RNA increase, P = 0.004) and between antibody responses to matrix and integrated HIV DNA in resting CD4+ T cells (0.35 fold-decrease per two-fold DNA increase, P = 0.003). However, these associations were not statistically significant after a stringent Bonferroni-adjustment of P<0.00045. Multivariate models including age and duration of ART did not markedly alter results.Our findings suggest that anti-HIV antibody responses may reflect the size of the HIV reservoir during chronic treated HIV disease, possibly via antigen recognition in reservoir sites. Larger, prospective studies are needed to validate the utility of antibody levels as a measure of the total body burden of HIV during treatment.http://europepmc.org/articles/PMC4970722?pdf=render
spellingShingle Sulggi A Lee
Peter Bacchetti
Nicolas Chomont
Remi Fromentin
Sharon R Lewin
Una O'Doherty
Sarah Palmer
Douglas D Richman
Janet D Siliciano
Steven A Yukl
Steven G Deeks
Peter D Burbelo
Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy.
PLoS ONE
title Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy.
title_full Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy.
title_fullStr Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy.
title_full_unstemmed Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy.
title_short Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy.
title_sort anti hiv antibody responses and the hiv reservoir size during antiretroviral therapy
url http://europepmc.org/articles/PMC4970722?pdf=render
work_keys_str_mv AT sulggialee antihivantibodyresponsesandthehivreservoirsizeduringantiretroviraltherapy
AT peterbacchetti antihivantibodyresponsesandthehivreservoirsizeduringantiretroviraltherapy
AT nicolaschomont antihivantibodyresponsesandthehivreservoirsizeduringantiretroviraltherapy
AT remifromentin antihivantibodyresponsesandthehivreservoirsizeduringantiretroviraltherapy
AT sharonrlewin antihivantibodyresponsesandthehivreservoirsizeduringantiretroviraltherapy
AT unaodoherty antihivantibodyresponsesandthehivreservoirsizeduringantiretroviraltherapy
AT sarahpalmer antihivantibodyresponsesandthehivreservoirsizeduringantiretroviraltherapy
AT douglasdrichman antihivantibodyresponsesandthehivreservoirsizeduringantiretroviraltherapy
AT janetdsiliciano antihivantibodyresponsesandthehivreservoirsizeduringantiretroviraltherapy
AT stevenayukl antihivantibodyresponsesandthehivreservoirsizeduringantiretroviraltherapy
AT stevengdeeks antihivantibodyresponsesandthehivreservoirsizeduringantiretroviraltherapy
AT peterdburbelo antihivantibodyresponsesandthehivreservoirsizeduringantiretroviraltherapy